• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西酞普兰治疗帕金森病行为症状致深静脉血栓形成和低钠血症:病例报告。

Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.

机构信息

Department of Internal Medicine, University of Tabuk, B.O.Box:4279, Tabuk City, 71491, Tabuk, Saudi Arabia.

出版信息

BMC Geriatr. 2023 Jun 1;23(1):344. doi: 10.1186/s12877-023-04057-z.

DOI:10.1186/s12877-023-04057-z
PMID:37264337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236744/
Abstract

BACKGROUND

Evidence is limited regarding the optimal therapeutic approach for neuropsychiatric symptoms associated with Parkinson's disease dementia (PDD). Selective serotonin reuptake inhibitors (SSRIs) are widely used for mood disorders and behavioral symptoms in older adults with cognitive impairment, but they have limited efficacy in patients with PDD. The effect of SSRIs on hemostasis is also unclear. This report describes a patient with PDD who developed deep venous thrombosis (DVT) and hyponatremia after initiating citalopram treatment.

CASE PRESENTATION

An 86-year-old woman with PDD presented to our emergency department with altered mental status, generalized weakness, and left lower leg swelling. Citalopram was begun 4 weeks previously for behavioral changes and was discontinued 2 days before presentation because of excessive fatigue. At presentation, her plasma sodium level was 123 mg/dL. Brain computed tomography showed age-related changes. Doppler ultrasound revealed a DVT in the left lower leg. The patient was treated with hypertonic saline and intravenous heparin. After normalization of her sodium, she was discharged on donepezil and apixaban. At follow-up, her sodium remained normal, and her cognition and behavior were noticeably improved.

CONCLUSION

Older adults with Parkinson's disease are sensitive to adverse effects of psychotropic agents, including SSRIs, which are not recommended first-line agents for behavioral symptoms in PDD. Upon initiating SSRIs in older patients with functional decline and multiple comorbidities, physicians need to evaluate the patient's risk factors for bleeding or thrombosis. Physical activities should also be maintained as much as possible.

摘要

背景

帕金森病痴呆(PDD)相关神经精神症状的最佳治疗方法证据有限。选择性 5-羟色胺再摄取抑制剂(SSRIs)广泛用于有认知障碍的老年人群的情绪障碍和行为症状,但在 PDD 患者中的疗效有限。SSRIs 对止血的影响也不清楚。本报告描述了一例 PDD 患者在开始西酞普兰治疗后出现深静脉血栓形成(DVT)和低钠血症。

病例介绍

一位 86 岁的女性 PDD 患者因精神状态改变、全身无力和左小腿肿胀到我院急诊科就诊。4 周前因行为改变开始服用西酞普兰,并在就诊前 2 天因过度疲劳停用。就诊时,其血浆钠水平为 123mg/dL。脑计算机断层扫描显示为与年龄相关的改变。多普勒超声显示左小腿 DVT。患者接受高渗盐水和静脉肝素治疗。钠恢复正常后,给予多奈哌齐和阿哌沙班出院。随访时,她的钠仍正常,认知和行为明显改善。

结论

帕金森病老年患者对精神药物的不良反应敏感,包括 SSRIs,不建议将其作为 PDD 行为症状的一线药物。在开始使用 SSRIs 治疗功能下降和合并多种疾病的老年患者时,医生需要评估患者出血或血栓形成的风险因素。还应尽可能保持身体活动。

相似文献

1
Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.西酞普兰治疗帕金森病行为症状致深静脉血栓形成和低钠血症:病例报告。
BMC Geriatr. 2023 Jun 1;23(1):344. doi: 10.1186/s12877-023-04057-z.
2
Recurrent escitalopram-induced hyponatremia in an elderly woman with dementia with Lewy bodies.反复发生的依他普仑致路易体痴呆老年女性低钠血症。
Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):101.e5-7. doi: 10.1016/j.genhosppsych.2011.06.007. Epub 2011 Aug 9.
3
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
4
Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.西酞普兰和文拉法辛所致抗利尿激素分泌不当综合征
Gen Hosp Psychiatry. 2007 Jan-Feb;29(1):81-4. doi: 10.1016/j.genhosppsych.2006.11.001.
5
Severe symptomatic hyponatremia during citalopram therapy--a case report.西酞普兰治疗期间出现严重症状性低钠血症——一例报告
BMC Nephrol. 2004 Jan 16;5:2. doi: 10.1186/1471-2369-5-2.
6
Citalopram-associated SIADH.西酞普兰相关的抗利尿激素分泌异常综合征
Ann Pharmacother. 2002 Oct;36(10):1558-63. doi: 10.1345/aph.1C071.
7
Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.西酞普兰引起的低钠血症和帕金森症:不容忽视的潜在致命副作用。
BMJ Case Rep. 2014 Nov 12;2014:bcr2014206575. doi: 10.1136/bcr-2014-206575.
8
Severe symptomatic hyponatremia during citalopram therapy.西酞普兰治疗期间出现严重症状性低钠血症。
Am J Med Sci. 2001 Feb;321(2):159-60. doi: 10.1097/00000441-200102000-00009.
9
Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Induced by Long-Term Use of Citalopram and Short-Term Use of Naproxen.长期使用西酞普兰和短期使用萘普生诱发的抗利尿激素分泌异常综合征(SIADH)
Am J Case Rep. 2020 Sep 18;21:e926561. doi: 10.12659/AJCR.926561.
10
Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.老年人中与选择性5-羟色胺再摄取抑制剂相关的低钠血症
Ann Pharmacother. 2006 Sep;40(9):1618-22. doi: 10.1345/aph.1G293. Epub 2006 Aug 8.

引用本文的文献

1
Post-traumatic cerebral venous sinus thrombosis complicated with syndrome of inappropriate antidiuretic hormone secretion: a case report.创伤后脑静脉窦血栓形成合并抗利尿激素分泌异常综合征:一例报告
J Med Case Rep. 2025 Mar 16;19(1):115. doi: 10.1186/s13256-025-05163-9.

本文引用的文献

1
Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: A systematic review and meta-analysis.抗抑郁药治疗对痴呆患者神经精神症状和激越的疗效:系统评价和荟萃分析。
Ageing Res Rev. 2021 Aug;69:101362. doi: 10.1016/j.arr.2021.101362. Epub 2021 May 14.
2
Response to commentary by Rhew and colleagues on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.对Rhew及其同事对《抑郁症、抗抑郁药使用与静脉血栓栓塞风险:已发表观察性证据的系统评价和荟萃分析》的评论的回应
Ann Med. 2019 Feb;51(1):99-100. doi: 10.1080/07853890.2019.1581942. Epub 2019 Apr 1.
3
Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs?抗抑郁药与静脉血栓栓塞风险:是疾病还是药物所致?
J Am Heart Assoc. 2017 May 17;6(5):e006293. doi: 10.1161/JAHA.117.006293.
4
The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics.抗抑郁药和抗精神病药使用者的血栓栓塞风险
Adv Exp Med Biol. 2017;906:351-361. doi: 10.1007/5584_2016_125.
5
Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies.选择性5-羟色胺再摄取抑制剂(SSRI)类抗抑郁药治疗下的出血风险:观察性研究的荟萃分析
Pharmacol Res. 2017 Apr;118:19-32. doi: 10.1016/j.phrs.2016.08.017. Epub 2016 Aug 10.
6
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.路易体痴呆的药物治疗:系统评价和荟萃分析。
Am J Psychiatry. 2015 Aug 1;172(8):731-42. doi: 10.1176/appi.ajp.2015.14121582. Epub 2015 Jun 18.
7
Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.选择性 5-羟色胺再摄取抑制剂与上消化道出血风险:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2015 Jan;13(1):42-50.e3. doi: 10.1016/j.cgh.2014.06.021. Epub 2014 Jun 30.
8
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.西酞普兰对阿尔茨海默病激越的影响:CitAD 随机临床试验。
JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.
9
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
10
Depression in Parkinson disease--epidemiology, mechanisms and management.帕金森病中的抑郁——流行病学、机制与管理。
Nat Rev Neurol. 2011 Dec 26;8(1):35-47. doi: 10.1038/nrneurol.2011.189.